Immunosuppressive role of fibrinogen-like protein 2 (FGL2) in CD8+regulatory T cells-mediated long-term graft survival by Bézie, Séverine et al.
ORAL PRESENTATION Open Access
Immunosuppressive role of fibrinogen-like
protein 2 (FGL2) in CD8
+regulatory T cells-
mediated long-term graft survival
Séverine Bézie
1*, Séverine Ménoret
2, Laurent Tesson
2, Xian-Liang Li
1, Claire Usal
1, Ignacio Anegon
1, Lise Caron
1
From 6th European Workshop on Immune-Mediated Inflammatory Diseases
Nice, France. 23-25 November 2011
Background
We have previously reported that, in a model of cardiac
allograft in rat, blockade of CD40-CD40L interaction
induces long-term graft survival mediated by CD8
+
CD45RC
low regulatory T cells (Tregs) [1]. Transcriptomic
comparison of Tregs from AdCD40Ig-treated vs naïve rats
highlighted the overexpression of FGL2 whose immunore-
gulatory properties are little known [2].
Material and methods
A lewis 1W rat heart is grafted in a MHC-mismatched
Lewis 1A rat and infected with 2.10
10pi of adenovirus
recombinant for CD40Ig molecule (AdCD40Ig) the day of
the graft. Tregs, effector CD4
+CD25
- T lymphocytes (TL),
and plasmacytoïde dendritic cells (pDC) from spleen are
sorted by FACS Aria for in vitro tests. For in vivo studies,
4,5.10
11vg of FGL2-recombinant adenovirus associated
virus (AAVFGL2) are intramuscularly or intravenously
injected in recipients 30 days before the graft. Splenocytes
are transferred to sublethaly irradiated rats by i.v injection
the day before the graft.
Results
We confirmed FGL2-overexpression in splenic Tregs and
in the graft of AdCD40Ig-treated vs non-treated and
naïve rats, at mRNA and protein level. FGL2 involvement
in Tregs immunosuppressive function was proved by in
vitro and in vivo experiments. Indeed, Tregs from
AdCD40Ig-treated rats inhibit TL proliferation in
response to allogeneic pDC. This inhibition is abrogated
by FGL2-blocking antibodies [3] and can be mimicked by
FGL2 protein alone. Moreover, AAV-mediated FGL2
overexpression in rat prolongs graft survival with a med-
i a no f1 8 . 5d a y sv s1 1d a y sf o rc o n t r o l sb yi . mi n j e c t i o n
and survival is improved when i.v injected. Furthermore,
adoptive transfer of splenocytes from an AAVFGL2-trea-
t e dt o l e r a n tr a t ,t oi r r a d i a t e drats, transmits long-term
graft survival iteratively.
Conclusions
This is the first demonstration that the immunosuppres-
sive molecule FGL2 is able to induce a long-term graft
survival and that this tolerance is active and transferable
by splenocytes. Work is under progress to identify the
population responsible for this infectious tolerance.
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